{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:07:53Z","timestamp":1790190473450,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40123-026-01356-7","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:54:49Z","timestamp":1774428889000},"page":"1847-1861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Irreversible Ocular and Systemic Damage in ROSAH Syndrome"],"prefix":"10.1007","volume":"15","author":[{"given":"Claudia","family":"Fabiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sbalchiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Gaggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cardamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"De Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Moscato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-1275","authenticated-orcid":false,"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/s41436-019-0476-3","volume":"21","author":"LB Williams","year":"2019","unstructured":"Williams LB, Javed A, Sabri A, Morgan DJ, Huff CD, Grigg JR, et al. ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder. Genet Med. 2019;21:2103\u201315.","journal-title":"Genet Med"},{"key":"1356_CR2","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.240260","volume":"14","author":"T Snelling","year":"2024","unstructured":"Snelling T, Garnotel LO, Jeru I, Tusseau M, Cuisset L, Perlat A, et al. Discovery and functional analysis of a novel ALPK1 variant in ROSAH syndrome. Open Biol. 2024;14:240260.","journal-title":"Open Biol"},{"key":"1356_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajo.2025.09.049","volume":"281","author":"Z Sun","year":"2026","unstructured":"Sun Z, Wei X, Han X, Liu H, Zou X, Li H, et al. Ocular manifestations of ROSAH syndrome caused by different mutations of the ALPK1 gene. Am J Ophthalmol. 2026;281:456\u201364.","journal-title":"Am J Ophthalmol."},{"key":"1356_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/09273948.2025.2453873","volume":"33","author":"L Mourozeau","year":"2025","unstructured":"Mourozeau L, Pichon V, Bouzidi A, Charif M, Tessarech M, Caignard A, et al. Two cases of ROSAH-like syndrome restricted to the ophthalmologic presentation. Ocul Immunol Inflamm. 2025;33:849\u201353.","journal-title":"Ocul Immunol Inflamm"},{"key":"1356_CR5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/annrheumdis-2022-222629","volume":"81","author":"CT Kozycki","year":"2022","unstructured":"Kozycki CT, Kodati S, Huryn L, Wang H, Warner BM, Jani P, et al. Gain-of-function mutations in ALPK1 cause an NF-\u03baB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. Ann Rheum Dis. 2022;81:1453\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 110","key":"1356_CR6","first-page":"3","volume":"36","author":"OM Lucherini","year":"2018","unstructured":"Lucherini OM, Rigante D, Sota J, Fabiani C, Obici L, Cattalini M, et al. Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases. Clin Exp Rheumatol. 2018;36(Suppl 110):3\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1356_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ophtha.2022.10.026","volume":"130","author":"LA Huryn","year":"2023","unstructured":"Huryn LA, Kozycki CT, Serpen JY, Zein WM, Ullah E, Iannaccone A, et al. Ophthalmic manifestations of ROSAH (retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache) syndrome, an inherited NF \u03baB-mediated autoinflammatory disease with retinal dystrophy. Ophthalmology. 2023;130:423\u201332.","journal-title":"Ophthalmology"},{"key":"1356_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ajmg.a.34437","volume":"158A","author":"SK Tantravahi","year":"2012","unstructured":"Tantravahi SK, Williams LB, Digre KB, Creel DJ, Smock KJ, DeAngelis MM, et al. An inherited disorder with splenomegaly, cytopenias, and vision loss. Am J Med Genet A. 2012;158A:475\u201381.","journal-title":"Am J Med Genet A"},{"key":"1356_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1356_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40123-023-00839-1","volume":"13","author":"C Gaggiano","year":"2024","unstructured":"Gaggiano C, Gupta V, Agrawal R, De Smet MD, Frediani B, Tosi GM, et al. Knowledge and current practices in monogenic uveitis: an international survey by IUSG and AIDA Network. Ophthalmol Ther. 2024;13:127\u201347.","journal-title":"Ophthalmol Ther"},{"key":"1356_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2025.1535805","volume":"5","author":"J Shunyakova","year":"2025","unstructured":"Shunyakova J, Reynolds M, Taylor A, Sieck EG, Walsh JT, Hassman LM. Case report: ROSAH syndrome presents diagnostic and therapeutic challenges. Front Ophthalmol. 2025;5:1535805.","journal-title":"Front Ophthalmol"},{"key":"1356_CR12","doi-asserted-by":"publisher","first-page":"1337329","DOI":"10.3389\/fopht.2024.1337329","volume":"4","author":"A Fonollosa","year":"2024","unstructured":"Fonollosa A, Carre\u00f1o E, Vitale A, Jindal AK, Ramanan AV, Pelegr\u00edn L, et al. Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases. Front Ophthalmol. 2024;4:1337329.","journal-title":"Front Ophthalmol"},{"issue":"Suppl 110","key":"1356_CR13","first-page":"44","volume":"36","author":"J Sota","year":"2018","unstructured":"Sota J, Vitale A, Fabiani C, Frediani B, Rigante D, Tosi GM, et al. The eye involvement in monogenic autoinflammatory diseases: literature review and update. Clin Exp Rheumatol. 2018;36(Suppl 110):44\u201353.","journal-title":"Clin Exp Rheumatol"},{"key":"1356_CR14","first-page":"2105","volume":"41","author":"A Fonollosa","year":"2023","unstructured":"Fonollosa A, Pelegr\u00edn L, Garc\u00eda-Morillo S, Buj\u00e1n-Rivas S, Distefano L, Robles-Maruenda A, et al. Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study. Clin Exp Rheumatol. 2023;41:2105\u201314.","journal-title":"Clin Exp Rheumatol"},{"key":"1356_CR15","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s10067-016-3527-z","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Sota J, Tosi GM, Franceschini R, Frediani B, Galeazzi M, et al. The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases. Clin Rheumatol. 2017;36:2307\u201318.","journal-title":"Clin Rheumatol"},{"key":"1356_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152430","volume":"66","author":"A Vitale","year":"2024","unstructured":"Vitale A, Caggiano V, Martin-Nares E, Frassi M, Dagna L, Hissaria P, et al. Orbital\/ocular inflammatory involvement in VEXAS syndrome: data from the international AIDA network VEXAS registry. Semin Arthritis Rheum. 2024;66:152430.","journal-title":"Semin Arthritis Rheum"},{"issue":"15","key":"1356_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12348-025-00550-1","volume":"21","author":"R Teixeira-Martins","year":"2025","unstructured":"Teixeira-Martins R, Faria-Pereira A, Figueiredo AS, d\u2019Oliveira R, Brito I, Rodrigues MJ, et al. Tocilizumab as a treatment tool for ROSAH syndrome: a case report. J Ophthalmic Inflamm Infect. 2025;21(15):87.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1356_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16665","volume":"9","author":"M Berman","year":"2023","unstructured":"Berman M, Berliner S, Bashouti N, Elkayam O, Ziv-Baran T. Reduced C-reactive protein level at hospital admission in patients treated with tocilizumab\u2014an attention may be required. Heliyon. 2023;9:e16665.","journal-title":"Heliyon"},{"key":"1356_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63731-5","volume":"16","author":"J Fan","year":"2025","unstructured":"Fan J, Liu D, Ming Z, Yan C, Dang H, Pan Y, et al. Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome. Nat Commun. 2025;16:8251.","journal-title":"Nat Commun"},{"key":"1356_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ajo.2017.08.019","volume":"183","author":"YJ Sepah","year":"2017","unstructured":"Sepah YJ, Sadiq MA, Chu DS, Dacey M, Gallemore R, Dayani P, et al. Primary (Month-6) outcomes of the STOP-Uveitis study: Evaluating the safety, tolerability, and efficacy of tocilizumab in patients with noninfectious uveitis. Am J Ophthalmol. 2017;183:71\u201380.","journal-title":"Am J Ophthalmol"},{"key":"1356_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/bjo-2025-327410","volume":"109","author":"J Sota","year":"2025","unstructured":"Sota J, Breda L, Paroli MP, Hashad S, de-la-Torre A, Guerriero S, et al. Tocilizumab effectiveness in paediatric non-infectious uveitis: data from the International AIDA Network Registries on ocular inflammatory disorders. Br J Ophthalmol. 2025;109:1151\u20134.","journal-title":"Br J Ophthalmol"},{"key":"1356_CR22","doi-asserted-by":"publisher","first-page":"13117","DOI":"10.2147\/JIR.S533011","volume":"18","author":"H Cao","year":"2025","unstructured":"Cao H, Bian K, Ma C, Zhang N, Ma X. Tocilizumab for non-infectious uveitis: a systematic review. J Inflamm Res. 2025;18:13117\u201338.","journal-title":"J Inflamm Res"},{"key":"1356_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-024-00443-9","volume":"14","author":"LS Zur Bonsen","year":"2024","unstructured":"Zur Bonsen LS, Schulze D, K\u00fcnzel SE, R\u00fcbsam A, Pleyer U, Pohlmann D. Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis. J Ophthalmic Inflamm Infect. 2024;14:61.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1356_CR24","doi-asserted-by":"publisher","first-page":"111563","DOI":"10.1016\/j.isci.2024.111563","volume":"28","author":"A Martin","year":"2024","unstructured":"Martin A, Caron S, Marcotte M, Bronnec P, Garneret E, Martel N, et al. IFN-\u03b3 licenses normal and pathogenic ALPK1\/TIFA pathway in human monocytes. iScience. 2024;28:111563.","journal-title":"iScience."},{"key":"1356_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.980679","volume":"9","author":"C Gaggiano","year":"2022","unstructured":"Gaggiano C, Vitale A, Tufan A, Ragab G, Aragona E, Wiesik-Szewczyk E, et al. The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases. Front Med (Lausanne). 2022;9:980679.","journal-title":"Front Med (Lausanne)"},{"key":"1356_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40123-022-00459-1","volume":"11","author":"FD Casa","year":"2022","unstructured":"Casa FD, Vitale A, Guerriero S, Sota J, Cimaz R, Ragab G, et al. Autoinflammatory Diseases Alliance (AIDA) Network. Development and implementation of the AIDA International Registry for patients with non-infectious uveitis. Ophthalmol Ther. 2022;11:899\u2013911.","journal-title":"Ophthalmol Ther"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01356-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01356-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01356-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:08:43Z","timestamp":1778749723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01356-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01356-7","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Valeria Caggiano, Jessica Sbalchiero, Carla Gaggiano, Chiara Cardamone, Maddalena De Bernardo, Valentina Giudice, Paolo Moscato, Nicola Rosa, Giuseppe Lopalco, Luca Cantarini, and Antonio Vitale have nothing to disclose. Claudia Fabiani is an Editorial Board member of Ophthalmology and Therapy. Claudia Fabiani was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The Ethics Committee of Azienda Ospedaliero-Universitaria Senese, Siena, Italy (Ref. N. 14951; NCT05200715) approved the study, which was performed according to the Good Clinical Practice guidelines and the Declaration of Helsinki (1964) and its later amendments. Written informed consent was obtained from all participants for both study participation and the publication of any potentially identifying information. The study protocol was also approved by the Ethics Committees of the other two participating centers, namely the University of Bari and the University of Salerno. Clinical data are kept in accordance with the EU General Data Protection Regulations (GDPR), or other counterparts, on the processing of personal data and the protection of privacy (2016\/679\/EU).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}